CH | China Factory | Cosmetic Peptides | 99% Purity | Lyophilized Powder | hign quality Betty
67769-47-5
Pharmaceutical
99%
HongKong
10vial
2026-11-03
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Product Description
-
Seller Information
-
DescriptionResearch & Reference Note
CH | China Factory | Cosmetic Peptides | 99% Purity | Lyophilized Powder | hign quality Betty is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
1H-Benz[de]isoquinoline-5,8-disulfonic acid, 6-amino-2-[(hydrazinylcarbonyl)amino]-2,3-dihydro-1,3-dioxo-, lithium salt (1:2)
Other Name:1H-Benz[de]isoquinoline-5,8-disulfonic acid,6-amino-2-[(hydrazinylcarbonyl)amino]-2,3-dihydro-1,3-dioxo-,lithium salt (1:2);1H-Benz[de]isoquinoline-5,8-disulfonic acid,6-amino-2-[(hydrazinocarbonyl)amino]-2,3-dihydro-1,3-dioxo-,dilithium salt;Lucifer Yellow CH;Lucifer Yellow carbohydrazide
CAS No.:67769-47-5
Molecular Formula:C13H11N5O9S2.2Li
InChIKeys:InChIKey=ZCJXKGHTBWNHMS-UHFFFAOYSA-N
Molecular Weight:445.4 g/mol
Exact Mass:444.99981929 g/mol
DSSTox ID:DTXSID70477326
Categories:
Characteristics-
PSA:
256 Ų
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Location:
1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product